Advertisement
Canada markets closed
  • S&P/TSX

    21,942.16
    +148.26 (+0.68%)
     
  • S&P 500

    5,482.87
    +4.97 (+0.09%)
     
  • DOW

    39,164.06
    +36.26 (+0.09%)
     
  • CAD/USD

    0.7283
    -0.0018 (-0.24%)
     
  • CRUDE OIL

    82.02
    +0.28 (+0.34%)
     
  • Bitcoin CAD

    85,063.20
    +1,292.00 (+1.54%)
     
  • CMC Crypto 200

    1,282.12
    +15.97 (+1.26%)
     
  • GOLD FUTURES

    2,333.90
    -2.70 (-0.12%)
     
  • RUSSELL 2000

    2,038.34
    +20.22 (+1.00%)
     
  • 10-Yr Bond

    4.2880
    -0.0280 (-0.65%)
     
  • NASDAQ futures

    20,086.50
    +47.00 (+0.23%)
     
  • VOLATILITY

    12.24
    -0.31 (-2.47%)
     
  • FTSE

    8,179.68
    -45.65 (-0.55%)
     
  • NIKKEI 225

    39,670.79
    +329.25 (+0.84%)
     
  • CAD/EUR

    0.6811
    -0.0006 (-0.09%)
     

Stocks in play: Canopy Growth Corporation

Today announced its financial results for the fourth quarter and fiscal year ended March 31, 2024. Canada cannabis net revenue in Q4 FY2024 increased 4% as compared to Q4 FY2023 led by a 16% increase in the Canada medical cannabis business. Operating loss from continuing operations of $229 MM in FY2024. Adjusted EBITDA loss was $59 MM in FY2024, representing an improvement of 72% year-over-year,Canopy Growth Corporation shares T.WEED are trading $1.48 at $13.07.

Read: